Author/Authors :
Masahiro Nomura، نويسنده , , Susumu Kinoshita، نويسنده , , Hiroya Satoh، نويسنده , , Toshio Maeda، نويسنده , , Koji Murakami، نويسنده , , Masaki Tsunoda، نويسنده , , Hiroyuki Miyachi، نويسنده , , Katsuya Awano، نويسنده ,
Abstract :
A series of 3-[(2,4-dioxothiazolidin-5-yl)methyl]benzamide derivatives was prepared as part of a search for antidiabetic agents. A structure-activity relationship study of these compounds led to the identification of 5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[4-(trifluoromethyl)-phenyl]methyl]benzamide (KRP-297) as a candidate drug for the treatment of diabetes mellitus.
